ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 638

Longitudinal Trends for Estimated Glomerular Filtration Rate and Predictors of Change in Patients with Systemic Lupus Erythematosus

Terry Cheuk Fung Yip 1, Michelle Petri 2 and Laurence Magder3, 1Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3University of Maryland School of Medicine, Baltimore, MD

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Clinical research, longitudinal studies and lupus nephritis, Renal disease, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: SLE – Clinical Poster I: Epidemiology & Pathogenesis

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: To characterize the longitudinal trajectory of estimated glomerular filtration rate (eGFR) in patients with systemic lupus erythematosus (SLE) and identify predictors of change in eGFR trajectory.

Methods: All patients with SLE who participated in a large American Lupus Cohort in or after year 2006 were identified. Patients were followed until death, diagnosis of end-stage renal disease or renal failure, or the last follow-up date, whichever came first. The longitudinal eGFR level of patients were modelled by piecewise linear regression. We evaluated the slope of different line segments. The slopes were classified into declining (≤ -4 mL/min/1.73 m2 per year), stable (-4 to 4 mL/min/1.73 m2 per year), and increasing (≥4 mL/min/1.73 m2 per year) states of eGFR. The transition rate between states and the impact of clinical parameters on transition rate were estimated using Proportional Hazards modeling. 

Results: We identified 494 SLE patients with 15,329 clinical visits over time. Two hundred and sixty-one (52.8%) patients were between 40 and 59 years old at the first clinical visit (baseline); 183 (37.0%) were younger than 40 years old; 50 (10.1%) were at or above 60 years old at baseline; 455 (92.1%) patients were female; 267 (54.0%) patients were Caucasian; 185 (37.4%) patients were African American. Their mean SLE disease activity index was 2.7 ± 3.4 at baseline. Three hundred and eight (62.3%) patients had an eGFR ≥90 mL/min/1.73 m2 at baseline; 152 (30.8%) had an eGFR between 60 and 89 mL/min/1.73 m2 at baseline; 34 (6.9%) had a baseline eGFR < 60 mL/min/1.73 m2. The eGFR trajectory of selected patients is shown in Figure 1. Of all patients, 34.4% experienced a declining state at some point in their follow-up. In patients with one transition, 43 (40.2%) changed from declining to stable state while 29 (27.1%) changed from stable to declining state. High blood pressure, low C4 and low hematocrit were associated with change from non-declining to declining state (Table 1). High urine protein-to-creatinine ratio also tended to be associated with change from non-declining to declining state. African American patients were less likely to move from declining to non-declining state. Use of prednisone was associated with change from declining to non-declining state (Table 2).

Conclusion: A declining eGFR trajectory is common in SLE patients. High blood pressure and urine protein-to-creatinine ratio, and low C4 and hematocrit are risk factors for transition from stable to declining GFR. Use of prednisone may attenuate the declining eGFR. These findings can help clinicians anticipate changes in GFR trajectory.

Figure 1. eGFR trajectory of selected patients -Gray line represents the estimated trajectory by piecewise linear regression. Black dot represents the eGFR of the patient in each visit-.


Table 1 GFR Abstract

Table 1. Univariate and multivariable predictiors of transition from non-declining state to declining state.


Table 2 GFR Abstract

Table 2. Univariate and multivariable predictiors of transition from declining to non-declining state.


Disclosure: T. Yip, None; M. Petri, Eli Lilly and Company, 5, Exagen, 2, 5; L. Magder, None.

To cite this abstract in AMA style:

Yip T, Petri M, Magder L. Longitudinal Trends for Estimated Glomerular Filtration Rate and Predictors of Change in Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/longitudinal-trends-for-estimated-glomerular-filtration-rate-and-predictors-of-change-in-patients-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/longitudinal-trends-for-estimated-glomerular-filtration-rate-and-predictors-of-change-in-patients-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology